[{"orgOrder":0,"company":"Kainos Medicine","sponsor":"Parexel","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"KM-819","moa":"FAS-associated factor 1 (FAF1)","graph1":"Neurology","graph2":"Phase II","graph3":"Kainos Medicine","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kainos Medicine \/ Parexel","highestDevelopmentStatusID":"8","companyTruncated":"Kainos Medicine \/ Parexel"},{"orgOrder":0,"company":"Kainos Medicine","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"KM-819","moa":"FAS-associated factor 1 (FAF1)","graph1":"Neurology","graph2":"Phase I","graph3":"Kainos Medicine","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kainos Medicine \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Kainos Medicine \/ Undisclosed"},{"orgOrder":0,"company":"Kainos Medicine","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"SOUTH KOREA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"KM-023","moa":"Human immunodeficiency virus Reverse transcriptase (HIV RT)","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Kainos Medicine","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Kainos Medicine \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Kainos Medicine \/ Undisclosed"},{"orgOrder":0,"company":"Kainos Medicine","sponsor":"Emmaus Life Sciences","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2021","type":"Collaboration","leadProduct":"KM10544","moa":"IRAK4","graph1":"Oncology","graph2":"Preclinical","graph3":"Kainos Medicine","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kainos Medicine \/ Emmaus Life Sciences","highestDevelopmentStatusID":"4","companyTruncated":"Kainos Medicine \/ Emmaus Life Sciences"}]